Crystal Interactions in Renal Stone Disease

肾结石疾病中的晶体相互作用

基本信息

  • 批准号:
    7284170
  • 负责人:
  • 金额:
    $ 25.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1982
  • 资助国家:
    美国
  • 起止时间:
    1982-07-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Kidney stone disease is a substantial health problem associated with significant pain, suffering, and economic costs. By the age of 70, 5% to 15% of the population will have a symptomatic episode of a stone and at least 50% of these individuals will have recurrent stone disease. Idiopathic calcium oxalate stone disease accounts for the majority of stone forming patients. It is generally accepted that idiopathic stone patients do not have dramatic anatomic, metabolic, or physiologic abnormalities. Idiopathic CaOx stone disease appears to require both supersaturation of the urine with respect to calcium and oxalate and tissue injury in the late collecting duct for crystals to attach, initiating stone development. The injury site appears to be highly localized to the site of the stone. Animal studies to date have used dramatic hyperoxaluric conditions that may have limited our ability to see the early events resulting from chronic mild hyperoxaluria as seen in idiopathic CaOx stone patients. No animal studies to date have explored the potential impact of chronic exposure of low levels of oxalate as might be seen in the idiopathic stone patients. This grant focuses on the attachment of urinary crystals to injured kidney papillary tip urothelium and the conditions and events that allow for crystal attachment. We will study long-term exposure of low to mild oxalate levels that might be associated with papillary tubular or vascular injury. The hypothesis to be tested is that CaOx crystal attachment to late collecting duct urothelium is dependent on localized injury that may originate in either the late collecting duct or in the vasculature intimately associated with the tubule crystal attachment site. We also hypothesize that chronic low levels of oxalate exposure as may be seen in idiopathic calcium oxalate stone patients may be sufficient to induce this injury. This grant proposal contains three Specific Aims to test this hypothesis. Specific Aim I: To determine if chronic exposure to oxalate levels insufficient for widespread CaOx crystal formation leads to the disruption of normal tubule physiology and the initiation of injury associated with effective urothelial crystal attachment and stone formation. Specific Aim II: To determine if tubule injury necessary for effective crystal attachment stems from oxalate-induced changes in the associated vasculature. Specific Aim III: To determine if oxalate-associated injury leading to effective CaOx crystal attachment and stone formation is exacerbated by the presence of other vascular and tubule injuries such as that associated with hypertension.
描述(由申请人提供):肾结石是一种严重的健康问题,与巨大的疼痛、痛苦和经济成本有关。到70岁时,5%至15%的人口将出现结石的症状发作,其中至少50%的人将复发结石疾病。特发性草酸钙结石占结石形成患者的大多数。人们普遍认为,特发性结石患者没有明显的解剖、代谢或生理异常。 特发性CaOx结石病似乎既需要尿液中钙和草酸的过饱和,也需要晚期收集管中的组织损伤以使晶体附着,从而启动结石的发展。受伤地点似乎高度局限于结石的位置。到目前为止,动物研究使用了戏剧性的高草酸条件,这可能限制了我们观察特发性CaOx结石患者慢性轻度高草酸尿引起的早期事件的能力。到目前为止,还没有动物研究探索慢性暴露于低水平草酸的潜在影响,就像在特发性结石患者中可能看到的那样。 这笔赠款的重点是将尿晶附着到受损的肾乳头状尖端尿路上皮,以及允许晶体附着的条件和事件。我们将研究长期暴露于低至轻度草酸水平,这可能与乳头状管或血管损伤有关。需要检验的假设是,CaOx晶体附着到晚收集管尿路上皮依赖于局部损伤,这种损伤可能起源于晚收集管或与小管晶体附着位置密切相关的血管系统。我们还假设,在特发性草酸钙结石患者中可以看到的慢性低水平草酸盐暴露可能足以导致这种损伤。这项拨款提案包含三个具体目标,以检验这一假设。 具体目标I:确定长期暴露于草酸水平是否不足以形成广泛的CaOx晶体,是否会导致正常肾小管生理的破坏,并引发与有效的尿路上皮晶体附着和结石形成相关的损伤。 具体目标II:确定有效的晶体附着所必需的小管损伤是否源于草酸引起的相关血管系统的变化。 具体目标三:确定与草酸相关的损伤导致有效的CaOx晶体附着和结石形成是否会因其他血管和小管损伤的存在而加剧,例如与高血压相关的损伤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEIL S. MANDEL其他文献

NEIL S. MANDEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEIL S. MANDEL', 18)}}的其他基金

Afferent arteriolar function and novel small molecules for renal radiation injury
入球小动脉功能和新型小分子治疗肾放射损伤
  • 批准号:
    9232964
  • 财政年份:
    2014
  • 资助金额:
    $ 25.08万
  • 项目类别:
Afferent arteriolar function and novel small molecules for renal radiation injury
入球小动脉功能和新型小分子治疗肾放射损伤
  • 批准号:
    8974351
  • 财政年份:
    2014
  • 资助金额:
    $ 25.08万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    6668065
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
Hyperoxaluria Leading to Tubule Injury and Kidney Stone Disease
高草酸尿症导致肾小管损伤和肾结石病
  • 批准号:
    6706400
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    7240567
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    6899909
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
Hyperoxaluria and Tubule Injury and Kidney Stone Disease
高草酸尿症、肾小管损伤和肾结石病
  • 批准号:
    6555901
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    6786585
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    7074768
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
CRYSTAL-MEMBRANE INTERACTIONS IN SILICOSIS
硅肺病中的晶膜相互作用
  • 批准号:
    3340945
  • 财政年份:
    1985
  • 资助金额:
    $ 25.08万
  • 项目类别:

相似海外基金

Understanding age at first autism health claim and acute health service use in girls and women relative to boys and men
了解女孩和女性相对于男孩和男性的首次自闭症健康声明和紧急医疗服务使用情况
  • 批准号:
    419977
  • 财政年份:
    2020
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Operating Grants
Proposal of a model plan for a high-activity operating department in an acute care hospital based on long-term PDCA in the age of minimally invasive treatment
微创治疗时代基于长期PDCA的急症医院高活动手术科室模型方案提出
  • 批准号:
    18K04486
  • 财政年份:
    2018
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ISCHAEMIC ACUTE RENAL FAILURE AND AGE: MODULATION BY ANTI-INFLAMMATORY EMBRYONIC STEM CELL-DERIVED MACROPHAGES
缺血性急性肾衰竭和年龄:抗炎胚胎干细胞源性巨噬细胞的调节
  • 批准号:
    G0801235/1
  • 财政年份:
    2009
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Research Grant
AGE-RELATED DIFFERENCES IN ENERGY EXPENDITURE IN RESPONSE TO ACUTE EXERCISE
剧烈运动时的能量消耗与年龄相关的差异
  • 批准号:
    7951393
  • 财政年份:
    2009
  • 资助金额:
    $ 25.08万
  • 项目类别:
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
  • 批准号:
    8306217
  • 财政年份:
    2008
  • 资助金额:
    $ 25.08万
  • 项目类别:
Age-related differences in the acute thermoregulatory responses to cold
对寒冷的急性体温调节反应与年龄相关的差异
  • 批准号:
    347633-2008
  • 财政年份:
    2008
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Postgraduate Scholarships - Master's
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
  • 批准号:
    7530462
  • 财政年份:
    2008
  • 资助金额:
    $ 25.08万
  • 项目类别:
Acute and chronic GPCR Medicated Cardioprotection: Roles of receptor Cross-Talk, Cellular signaling, and effects of Age
急性和慢性 GPCR 药物心脏保护:受体串扰的作用、细胞信号传导以及年龄的影响
  • 批准号:
    nhmrc : 428251
  • 财政年份:
    2008
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Career Development Fellowships
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
  • 批准号:
    8134266
  • 财政年份:
    2008
  • 资助金额:
    $ 25.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了